Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

CarMoney shareholders approved the additional share issue

1/13/25 CARM

Histograft' material undergoes study for spine treatment

1/13/25 ABIO

Gazprom may cut its central staff almost in half

1/13/25 GAZP

Sber, T-bank and Alfa-Bank set up a payment consortium operator

1/13/25 T

Sber, T-bank and Alfa-Bank set up a payment consortium operator

1/13/25 SBER

MGKL revenue to quadruple in 2024

1/13/25 MGKL

Joint project of Lukoil and Gazprom hit by sanctions

1/10/25 LKOH

Gazprom Shelfproject and RusGazAlliance are on the sanctions list

1/10/25 GAZP

Polar Lithium has fallen under sanctions

1/10/25 GMKN

Gazprom's LNG plant on the Baltic Sea hit by sanctions

1/10/25 GAZP